Updates from ASBrS 2017

8 May 2017 As a past-president of the American Society of Breast Surgeons I am probably more than a little biased. However, as always, the annual meeting held April 26-30th in Las Vegas was terrific. Topics including the full spectrum of breast disease, including benign and high risk lesions, genetic testing, breast cancer diagnosis and treatment including medical and radiation…

Read more

Active Surveillance for DCIS

20 March 2017 Over 50,000 women in the US are diagnosed every year with ductal carcinoma in-situ (DCIS), also known as Stage 0 breast cancer. DCIS is most often diagnosed on screening mammography and usually presents as a cluster of calcium deposits rather than a lump. In cases of DCIS, malignant appearing cells grow within the milk duct, but do not invade…

Read more

Misunderstanding Prognosis and Test Results

17 January 2017 A study recently published in the Journal of Oncology Practice noted that patients with incurable breast cancer often have poor awareness of their prognosis after oncologist discussion of scan results. The researchers analyzed audio recordings of conversations between patients and oncologists. They found that oncologists tended to spend more time discussing treatment recommendations rather than scan results…

Read more

Extended Endocrine Therapy – Not So Fast?

26 December 2016 Approximately 75% of breast cancers express the estrogen receptor – we term these breast cancers ER positive (ER+) or hormone-sensitive. Endocrine therapy refers to using medications to exploit this cancer cell property. Tamoxifen is used in premenopausal women and it blocks the estrogen receptor. In post-menopausal women, aromatase inhibitors (AI) are used which prevent estrogen from being produced…

Read more

Accelerated Aging Due to Cancer Treatment

28 November 2016 Cancer treatment takes a physical and mental toll. As patients progress from active treatment into the survivorship phase, many become frustrated that they cannot “bounce back” as quickly as they would like. Getting back to “normal” may not be realistic – many of us are doing way too much even on a good day, and ignore the…

Read more

A Crucial Catch to Address Breast Cancer Disparities

25 October 2016 For the past several years, the NFL has gone pink in October. At first glance, it appears that the “Crucial Catch” campaign is simply another pinkwashing project. The campaign message: screening saves lives. Unfortunately, it’s not that simple. Proceeds from the auction of pink apparel, commemorative coins and other items are donated to the American Cancer Society’s CHANGE program –…

Read more

Metastatic Breast Cancer

13 October 2016 The 13th of October is designated for metastatic breast cancer awareness. Metastatic, or Stage IV breast cancer, is when the cancer has spread outside of the breast or underarm lymph nodes. The most common sites of spread are the bones, liver, lung and brain.  Later stage of disease at the time of diagnosis is a risk factor, as…

Read more

Surveillance in Patients with Metastatic Breast Cancer

25 August 2016 Patients with metastatic (Stage IV) breast cancer often undergo frequent blood tests and scans to monitor for disease progression. But is there such a thing as too much testing? A study recently published in the Journal of the American Society of Clinical Oncology evaluated the use of blood tests (tumor markers) and body imaging scans (such as PET,…

Read more

Do I Need Chemotherapy?

25 August 2016 A study published today in the New England Journal of Medicine reports on the 5 year results of the MINDACT (Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy) trial. This study was designed to evaluate the use of a tumor gene signature test (MammaPrint) compared with standard factors to assess the…

Read more

SSO – ASTRO – ASCO DCIS Margin Guidelines

15 August 2016 A consensus statement was released today by the Society of Surgical Oncology,the American Society for Radiation Oncology, and the American Society of Clinical Oncology. It addresses the issue of surgical margins for patients undergoing breast conserving surgery (lumpectomy) for ductal carcinoma in-situ (DCIS).The press release provides a summary of the important findings. We know from many years of…

Read more
Pages